Clinical Trial Update: Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes [NA]

View source ↗

Summary

A completed clinical trial evaluating the impact of sitagliptin on cardiovascular exercise performance in adults with type 2 diabetes and cardiovascular disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Type 2 Diabetes, Cardiovascular Disease | NA | Status: COMPLETED | Results posted: 2019-05-22